The company
Agios Pharmaceuticals, Inc.
AGIO · Nasdaq
AGIO stood above a rising 150-day average in 17 of the last 52 weekly readings, including each of the last 1 week. It is 13.0% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 1 in a row
- Industry in uptrend
- 18% -14 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $9.2M
- Officials’ trades on record
- 9
- Institutions holding
- 221 (+6)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
9 disclosed lines: House 8, Senate 0, executive 1; 4 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 20 Aug 2026filed 10 Sep 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 3 Mar 2026filed 7 Apr 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 11 Dec 2025filed 12 Jan 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 17 Apr 2025filed 6 May 2025 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 29 Jan 2025filed 11 Feb 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 24 Jan 2024filed 15 Feb 2024 |
| Eric S. Lander Executive branch: Office of Government EthicsOffice of Science and Technology Policy | sold | $15k–$50k | 10 Jun 2021filed 8 Sep 2021 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | sold | $1k–$15k | 27 May 2015filed 7 Jun 2015 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | bought | $1k–$15k | 18 Mar 2015filed 11 Apr 2015 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Sarah GheuensChief Medical Officer | sold | 30,000at $30.48 | 4 Aug 2026filed 6 Aug 2026 |
| Sarah GheuensChief Medical Officer | sold | 4,007at $37.56 | 1 Jul 2026filed 2 Jul 2026 |
| Brian GoffChief Executive Officer | sold | 12,472at $34.71 | 2 Apr 2026filed 6 Apr 2026 |
| Brian GoffChief Executive Officer | sold | 6,596at $34.71 | 2 Apr 2026filed 6 Apr 2026 |
| Krishnan ViswanadhanChief Corp Dev & Strategy | sold | 2,959at $34.71 | 2 Apr 2026filed 6 Apr 2026 |
| Tsveta MilanovaChief Commercial Officer | sold | 3,262at $34.71 | 2 Apr 2026filed 6 Apr 2026 |
| Cecilia JonesChief Financial Officer | sold | 3,141at $34.71 | 2 Apr 2026filed 6 Apr 2026 |
| Sarah GheuensChief Medical Officer | sold | 2,940at $34.71 | 2 Apr 2026filed 6 Apr 2026 |
| James William BurnsChief Legal Officer | sold | 3,280at $34.71 | 2 Apr 2026filed 6 Apr 2026 |
| Krishnan ViswanadhanChief Corp Dev & Strategy | sold | 2,959at $27.80 | 5 Mar 2026filed 9 Mar 2026 |
| Theodore James Washburn, Jr.Principal Accounting Officer | sold | 5,272at $28.88 | 3 Mar 2026filed 5 Mar 2026 |
| Theodore James Washburn, Jr.Principal Accounting Officer | sold | 698at $28.96 | 2 Mar 2026filed 3 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 6,455,997$239.6M | +701,040+12.2% |
| FARALLON CAPITAL MANAGEMENT, L.L.C.added · filed 14 Aug 2026 | 5,917,400$219.6M | +233,400+4.1% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,533,633$131.1M | +168,754+5.0% |
| Lynx1 Capital Management LPadded · filed 12 Aug 2026 | 3,408,937$126.5M | +797,369+30.5% |
| D. E. Shaw & Co., Inc.added · filed 14 Aug 2026 | 3,107,005$115.3M | +425,836+15.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,898,197$107.6M | +287,162+11.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,681,845$99.5M | +49,529+1.9% |
| ARMISTICE CAPITAL, LLCreduced · filed 14 Aug 2026 | 2,400,000$89.1M | -316,000−11.6% |
| Erste Asset Management GmbHreduced · filed 28 Jul 2026 | 2,154,900$82.0M | -550,000−20.3% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC.added · filed 14 Aug 2026 | 2,110,809$78.3M | +616,374+41.2% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.